

G Amphray Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.95 Cr
- Paid Up Capital ₹ 1.10 M
- Company Age 43 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 70.07%
- Profit Growth 78.16%
- Ebitda 79.50%
- Net Worth 35.65%
- Total Assets 19.09%
About G Amphray Pharmaceuticals
G Amphray Pharmaceuticals Private Limited (GAPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 27 February 1982 and has a history of 43 years and two months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.95 Cr and a paid-up capital of Rs 1.10 M, as per Ministry of Corporate Affairs (MCA) records.
Grace Deora, Rajesh Deora, and Rajiv Deora serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24200MH1982PTC026504
- Company No.
026504
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Feb 1982
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at G Amphray Pharmaceuticals?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Grace Deora ![]() | Director | 03-Sep-2006 | Current |
Rajesh Deora ![]() | Director | 21-Jun-2005 | Current |
Rajiv Deora ![]() | Director | 27-Dec-1990 | Current |
Financial Performance of G Amphray Pharmaceuticals.
G Amphray Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 70.07% increase. The company also saw a substantial improvement in profitability, with a 78.16% increase in profit. The company's net worth Soared by an impressive increase of 35.65%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of G Amphray Pharmaceuticals?
In 2023, G Amphray Pharmaceuticals had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Triochem Products Limited
Grace Deora and Rajesh Deora are mutual person
- G Amphray Laboratories Llp
Rajesh Deora is a mutual person
- Triochem Laboratories Pvt Ltd
Grace Deora, Rajesh Deora and 1 more are mutual person
- Ambernath Plasto Packaging Pvt Ltd
Grace Deora, Rajesh Deora and 1 more are mutual person
- Deora Investments Private Limited
Grace Deora and Rajiv Deora are mutual person
Charges (Loans)

There are no open charges registered against the company as per our records.
How Many Employees Work at G Amphray Pharmaceuticals?
G Amphray Pharmaceuticals has a workforce of 20 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of G Amphray Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped G Amphray Pharmaceuticals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on G Amphray Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
G Amphray Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.
- Balance Sheet
G Amphray Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
- Director Appointment
Grace Ramu Deora was appointed as a Director was appointed as a Director on 03 Sep 2006 & has been associated with this company since 18 years 8 months .
- Director Appointment
Rajesh Ramu Deora was appointed as a Director was appointed as a Director on 21 Jun 2005 & has been associated with this company since 19 years 10 months .
- Director Appointment
Rajiv Ramu Deora was appointed as a Director was appointed as a Director on 27 Dec 1990 & has been associated with this company since 34 years 4 months .
- Company Incorporation
G Amphray Pharmaceuticals Private Limited was registered on 27 Feb 1982 with Roc Mumbai & aged 43 years 2 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of G Amphray Pharmaceuticals Private Limited?
G Amphray Pharmaceuticals Private Limited was incorporated on 27 Feb 1982.
What is authorized share capital and paid-up capital of G Amphray Pharmaceuticals Private Limited?
The authorized share capital of G Amphray Pharmaceuticals Private Limited is ₹ 1.95 Cr and paid-up capital is ₹ 1.10 M.
Who are the current board members & directors of G Amphray Pharmaceuticals Private Limited?
Currently 3 directors are associated with G Amphray Pharmaceuticals Private Limited.
- Grace Ramu Deora
- Rajesh Ramu Deora
- Rajiv Ramu Deora
What is the registered address of G Amphray Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of G Amphray Pharmaceuticals Private Limited is Sambava Chambers 4Th Floorsir P M Road India, Mumbai, Maharashtra, 400001.
What is the corporate identification number (CIN) and company number of G Amphray Pharmaceuticals Private Limited?
The corporate identification number (CIN) of G Amphray Pharmaceuticals Private Limited is U24200MH1982PTC026504 and the company number is 026504 as per Ministry of Corporate Affairs (MCA).
What is the official website of G Amphray Pharmaceuticals Private Limited?
The Official website of G Amphray Pharmaceuticals Private Limited is https://www.amphray.com
What has been the recent revenue trend for G Amphray Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for G Amphray Pharmaceuticals Private Limited has risen by 70.07%.
How many employees does G Amphray Pharmaceuticals Private Limited currently have?
As Per 2023 financial reports, 20 employees are currently employed by G Amphray Pharmaceuticals Private Limited.
What change has been observed in the net worth of G Amphray Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of G Amphray Pharmaceuticals Private Limited has experienced an upsurge of 35.65%.
When was the last Balance Sheet of G Amphray Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for G Amphray Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records